Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adenocarcinoma, Tubular
|
3 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.020 | 1.000 | 2 | 2007 | 2018 | ||||||
Adenocarcinoma of lung stage IIIB
|
3 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Adenocarcinoma, metastatic
|
3 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||||
Adult Penile Carcinoma
|
3 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Malignant neoplasm of penis
|
3 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
newly diagnosed non-small cell lung cancer
|
3 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Papillary adenocarcinoma
|
3 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Penis carcinoma
|
3 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Stage IA Lung Adenocarcinoma AJCC v7
|
3 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Non-small cell lung cancer recurrent
|
4 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.020 | 1.000 | 2 | 2015 | 2017 | ||||||
Non-squamous non-small cell lung cancer
|
4 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.020 | 1.000 | 2 | 2016 | 2018 | ||||||
Myoma
|
4 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA
|
5 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.040 | 1.000 | 4 | 2012 | 2017 | ||||||
Adenocarcinoma of small intestine
|
5 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Bronchioloalveolar Adenocarcinoma
|
5 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||
Adenocarcinoma of lung, stage IV
|
6 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.040 | 1.000 | 4 | 2013 | 2019 | ||||||
Pleural Effusion, Malignant
|
6 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.030 | 1.000 | 3 | 2011 | 2015 | ||||||
Carcinoma, Large Cell
|
6 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Mucoepidermoid Carcinoma
|
6 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
Primary Lesion
|
8 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Metastatic Malignant Neoplasm to the Leptomeninges
|
9 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.030 | 1.000 | 3 | 2009 | 2019 | ||||||
Advanced lung cancer
|
9 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
Metastatic Lung Adenocarcinoma
|
10 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.030 | 1.000 | 3 | 2014 | 2018 | ||||||
Lymphatic Metastasis
|
10 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Mucinous Adenocarcinoma
|
10 | 0.568 | 0.560 | 7 | 55191822 | missense variant | T/A;G | snv | 0.010 | 1.000 | 1 | 2012 | 2012 |